The stoichiometric transition from Zn6Cu1-metallothionein to Zn7-metallothionein underlies the up-regulation of metallothionein (MT) expression: quantitative analysis of MT-metal load in eye cells.
We examined the profiling of gene expression of metallothioneins (MTs) in human tissues from cadaver eyes with microarray-based analysis. All MT1 isoforms, with the exception of MT1B, were abundantly expressed in lens and corneal tissue. Along with MT1B, MT4 was not detected in any tissues. Antibodies to MT1/2 labeled the corneal epithelial and endothelial cells, whereas MT3 label the retinal ganglion cells. We studied the effects of zinc and cytokines on the gene expression of MT isoforms in a corneal epithelial cell line (HCEsv). Zinc exerted an up-regulation of the expression of MT isoforms, and this effect was further potentiated in the presence of IL1α or TNFα. Zinc also elicited a strong down-regulation of the expression of inflammatory cytokines, and this effect was blocked in the presence of TNFα or IL1α. The concentration of MTs, bound zinc, and the metal stoichiometry of MTs in cultured HCEsv were determined by mass spectrometry. The total concentration of MTs was 0.24 ± 0.03 μM and, after 24 h of zinc exposure, increased to 0.96 ± 0.01 μM. The combination of zinc and IL1α further enhanced the level of MTs to 1.13 ± 0.03 μM. The average metal stoichiometry of MTs was Zn(6)Cu(1)-MT, and after exposure to the different treatments, it changed to Zn(7)-MT. Actinomycin D blocked transcription, and cycloheximide attenuated synthesis of MTs in the presence or absence of zinc, suggesting transcriptional regulation. Overall the data provide molecular and analytical evidence on the interplay between zinc, MTs, and proinflammatory cytokines in HCEsv cells, with potential implications on cell-based inflammatory eye diseases.
Fundación de Investigación Oftalmológica, Instituto Oftalmológico Fernández-Vega, 33012 Oviedo, Spain.
Lydia
L
Alvarez
Hector
H
Gonzalez-Iglesias
Montserrat
M
Garcia
Sikha
S
Ghosh
Alfredo
A
Sanz-Medel
Miguel
M
Coca-Prados
D000368:Aged; D000369:Aged, 80 and over; D002478:Cells, Cultured; D003300:Copper / Q000378:metabolism*; D004847:Epithelial Cells / Q000166:cytology / Q000378:metabolism; D005123:Eye / Q000166:cytology / Q000378:metabolism*; D005136:Eye Proteins / Q000096:biosynthesis*; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D053582:Interleukin-1alpha / Q000378:metabolism / Q000494:pharmacology; D008297:Male; D008668:Metallothionein / Q000096:biosynthesis*; D015032:Zinc / Q000378:metabolism*
D005136:Eye Proteins; C508584:IL1A protein, human; D053582:Interleukin-1alpha; C554597:metallothionein-4, human; D003300:Copper; D008668:Metallothionein; D015032:Zinc